Mystic Asset Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$465K Buy
1,284
+4
+0.3% +$1.37K 0.1% 157
2026
Q1
$450K Hold
1,280
– – 0.1% 152
2025
Q4
$419K Hold
1,280
– – 0.09% 154
2025
Q3
$361K Hold
1,280
– – 0.08% 171
2025
Q2
$357K Hold
1,280
– – 0.09% 167
2025
Q1
$399K Buy
1,280
+13
+1% +$3.84K 0.11% 154
2024
Q4
$330K Buy
1,267
+546
+76% +$162K 0.09% 166
2024
Q3
$232K Hold
721
– – 0.09% 162
2024
Q2
$225K Hold
721
– – 0.09% 152
2024
Q1
$205K Buy
721
+4
+0.6% +$1.17K 0.08% 158
2023
Q4
$207K Buy
+717
New +$195K 0.1% 153
2022
Q1
– Sell
-535
Closed -$120K – 166
2021
Q4
$120K Buy
+535
New +$113K 0.06% 183

Other funds holding AMGN

Mystic Asset Management's AMGN Position: Q2 2026 in Review

Mystic Asset Management increased its Amgen (AMGN) stake by 0.31% in Q2 2026, buying an estimated $1.37K and bringing the position to 1,284 shares worth $465K. The position accounts for 0.1% of the portfolio, ranked #157.

Mystic Asset Management first reported a position in AMGN in Q4 2021 and has held it in 12 quarters since. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Mystic Asset Management held 1,284 shares of Amgen worth $465K as of Q2 2026.
  • Mystic Asset Management bought 4 Amgen shares in Q2 2026, an estimated $1.37K.
  • Amgen made up 0.1% of Mystic Asset Management's portfolio in Q2 2026, its #157 holding.
  • Mystic Asset Management first reported a position in Amgen in Q4 2021 and has held it in 12 quarters since.
  • 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Mystic Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.